vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Via Renewables, Inc. (VIASP). Click either name above to swap in a different company.

Via Renewables, Inc. is the larger business by last-quarter revenue ($127.8M vs $77.6M, roughly 1.6× Bioceres Crop Solutions Corp.). Via Renewables, Inc. runs the higher net margin — 5.4% vs -9.6%, a 15.0% gap on every dollar of revenue. On growth, Via Renewables, Inc. posted the faster year-over-year revenue change (22.5% vs -16.8%). Over the past eight quarters, Via Renewables, Inc.'s revenue compounded faster (5.9% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

EDF Power Solutions is a wholly owned subsidiary of the French utility EDF Group, specializing in renewable energy production. As an integrated operator, the Group develops and finances the construction of renewable energy facilities, and manages operations and maintenance for its own account and for third parties.

BIOX vs VIASP — Head-to-Head

Bigger by revenue
VIASP
VIASP
1.6× larger
VIASP
$127.8M
$77.6M
BIOX
Growing faster (revenue YoY)
VIASP
VIASP
+39.3% gap
VIASP
22.5%
-16.8%
BIOX
Higher net margin
VIASP
VIASP
15.0% more per $
VIASP
5.4%
-9.6%
BIOX
Faster 2-yr revenue CAGR
VIASP
VIASP
Annualised
VIASP
5.9%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
VIASP
VIASP
Revenue
$77.6M
$127.8M
Net Profit
$-7.4M
$6.9M
Gross Margin
46.8%
34.4%
Operating Margin
9.3%
15.2%
Net Margin
-9.6%
5.4%
Revenue YoY
-16.8%
22.5%
Net Profit YoY
-20.2%
-30.9%
EPS (diluted)
$-0.12
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
VIASP
VIASP
Q4 25
$127.8M
Q3 25
$77.6M
$103.3M
Q2 25
$90.0M
Q1 25
$60.6M
$142.3M
Q4 24
$98.8M
$104.3M
Q3 24
$93.3M
$93.8M
Q2 24
$86.7M
Q1 24
$84.0M
$114.1M
Net Profit
BIOX
BIOX
VIASP
VIASP
Q4 25
$6.9M
Q3 25
$-7.4M
$757.0K
Q2 25
$2.7M
Q1 25
$-1.6M
$8.8M
Q4 24
$605.2K
$9.9M
Q3 24
$-6.2M
$2.1M
Q2 24
$7.6M
Q1 24
$9.8M
$8.6M
Gross Margin
BIOX
BIOX
VIASP
VIASP
Q4 25
34.4%
Q3 25
46.8%
23.1%
Q2 25
30.0%
Q1 25
39.4%
32.9%
Q4 24
42.0%
51.9%
Q3 24
40.2%
26.8%
Q2 24
50.4%
Q1 24
50.8%
39.5%
Operating Margin
BIOX
BIOX
VIASP
VIASP
Q4 25
15.2%
Q3 25
9.3%
3.1%
Q2 25
6.7%
Q1 25
1.5%
17.5%
Q4 24
14.5%
31.5%
Q3 24
2.5%
5.3%
Q2 24
23.8%
Q1 24
15.7%
22.6%
Net Margin
BIOX
BIOX
VIASP
VIASP
Q4 25
5.4%
Q3 25
-9.6%
0.7%
Q2 25
3.0%
Q1 25
-2.6%
6.2%
Q4 24
0.6%
9.5%
Q3 24
-6.6%
2.3%
Q2 24
8.8%
Q1 24
11.6%
7.5%
EPS (diluted)
BIOX
BIOX
VIASP
VIASP
Q4 25
$1.19
Q3 25
$-0.12
$-0.41
Q2 25
$0.09
Q1 25
$-0.02
$1.83
Q4 24
$0.00
$2.33
Q3 24
$-0.10
$-0.17
Q2 24
$1.51
Q1 24
$0.14
$1.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
VIASP
VIASP
Cash + ST InvestmentsLiquidity on hand
$15.5M
$41.8M
Total DebtLower is stronger
$120.0M
Stockholders' EquityBook value
$288.3M
$67.7M
Total Assets
$734.9M
$331.3M
Debt / EquityLower = less leverage
1.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
VIASP
VIASP
Q4 25
$41.8M
Q3 25
$15.5M
$53.6M
Q2 25
$62.1M
Q1 25
$38.5M
$64.7M
Q4 24
$29.2M
$53.1M
Q3 24
$32.3M
$66.6M
Q2 24
$53.6M
Q1 24
$16.4M
$50.4M
Total Debt
BIOX
BIOX
VIASP
VIASP
Q4 25
$120.0M
Q3 25
$105.0M
Q2 25
$100.0M
Q1 25
$101.0M
Q4 24
$106.0M
Q3 24
$89.0M
Q2 24
$93.0M
Q1 24
$91.0M
Stockholders' Equity
BIOX
BIOX
VIASP
VIASP
Q4 25
$67.7M
Q3 25
$288.3M
$63.7M
Q2 25
$68.2M
Q1 25
$345.0M
$72.7M
Q4 24
$346.3M
$66.7M
Q3 24
$346.0M
$58.2M
Q2 24
$58.3M
Q1 24
$348.5M
$53.2M
Total Assets
BIOX
BIOX
VIASP
VIASP
Q4 25
$331.3M
Q3 25
$734.9M
$304.8M
Q2 25
$316.3M
Q1 25
$798.2M
$347.4M
Q4 24
$835.2M
$344.9M
Q3 24
$827.3M
$298.4M
Q2 24
$299.7M
Q1 24
$836.1M
$302.7M
Debt / Equity
BIOX
BIOX
VIASP
VIASP
Q4 25
1.77×
Q3 25
1.65×
Q2 25
1.47×
Q1 25
1.39×
Q4 24
1.59×
Q3 24
1.53×
Q2 24
1.60×
Q1 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
VIASP
VIASP
Operating Cash FlowLast quarter
$14.4M
$-4.2M
Free Cash FlowOCF − Capex
$-4.8M
FCF MarginFCF / Revenue
-3.7%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
-0.61×
TTM Free Cash FlowTrailing 4 quarters
$39.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
VIASP
VIASP
Q4 25
$-4.2M
Q3 25
$14.4M
$2.4M
Q2 25
$19.0M
Q1 25
$23.3M
$24.9M
Q4 24
$-5.4M
$2.0M
Q3 24
$5.2M
$20.1M
Q2 24
$11.2M
Q1 24
$-17.4M
$17.1M
Free Cash Flow
BIOX
BIOX
VIASP
VIASP
Q4 25
$-4.8M
Q3 25
$1.9M
Q2 25
$18.4M
Q1 25
$23.5M
Q4 24
$1.6M
Q3 24
$19.7M
Q2 24
$10.9M
Q1 24
$16.6M
FCF Margin
BIOX
BIOX
VIASP
VIASP
Q4 25
-3.7%
Q3 25
1.9%
Q2 25
20.5%
Q1 25
16.5%
Q4 24
1.5%
Q3 24
21.0%
Q2 24
12.6%
Q1 24
14.6%
Capex Intensity
BIOX
BIOX
VIASP
VIASP
Q4 25
0.4%
Q3 25
0.4%
Q2 25
0.6%
Q1 25
1.0%
Q4 24
0.4%
Q3 24
0.4%
Q2 24
0.3%
Q1 24
0.4%
Cash Conversion
BIOX
BIOX
VIASP
VIASP
Q4 25
-0.61×
Q3 25
3.12×
Q2 25
6.94×
Q1 25
2.84×
Q4 24
-8.85×
0.20×
Q3 24
9.41×
Q2 24
1.47×
Q1 24
-1.78×
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

VIASP
VIASP

Retail Electricity$79.7M62%
Retail Natural Gas$48.9M38%

Related Comparisons